Aquestive Therapeutics, Inc.
(NASDAQ : AQST)

( )
AQST After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
1.81%135.240.7%$927.17m
PFEPfizer Inc.
-0.41%36.350.9%$655.44m
MRKMerck & Co., Inc.
-0.68%84.460.7%$633.87m
ABBVAbbVie, Inc.
0.38%74.782.3%$554.75m
BMYBristol-Myers Squibb Company
-0.62%51.511.4%$499.07m
LLYEli Lilly and Company
-1.55%108.001.0%$300.36m
NVSNovartis AG Sponsored ADR
0.35%87.000.2%$147.02m
AZNAstraZeneca PLC Sponsored ADR
-0.95%43.791.2%$141.16m
GSKGlaxoSmithKline plc Sponsored ADR
0.04%42.290.3%$93.88m
SNYSanofi Sponsored ADR
0.40%45.740.2%$79.58m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.36%52.280.1%$70.77m
LCILannett Company, Inc.
1.43%11.3835.6%$16.40m
AKTXAkari Therapeutics Plc Sponsored ADR
2.31%1.771.6%$0.56m
EPIXESSA Pharma Inc
-3.34%3.330.1%$0.10m

Company Profile

Aquestive Therapeutics, Inc. is a specialty pharmaceutical company focused on identifying, developing, and commercializing differentiated products to address unmet medical needs. The company has a late-stage proprietary product pipeline focused on the treatment of Central nervous system (CNS) diseases, as well as orally-administered complex molecules that can be alternatives to invasively-administered standard of care therapies. Its product candidates include Libervant, Sympazan, and AQST-117 (Riluzole). Aquestive Therapeutics develops and delivers drugs via its PharmFilm® technology. The firm also collaborates with pharmaceutical partners to bring new molecules to market in differentiated and highly-marketable dosage forms. In addition to its proprietary product candidates, the company, with its partners, has a portfolio of development-stage products and commercialized products, such as Suboxone, a prescription medicine for the treatment of opioid dependence. The company was founded in January 2004 and is headquartered in Warren, NJ.